Chengju Pharmaceutical was established in June 2013;

In September 2019, the company was recognized as a "National High-Tech Enterprise";

In February 2020, it undertook the production task of disinfectants for combating the COVID-19 pandemic in Shangrao City, cumulatively donating over 50 tons to Hubei Province for pandemic relief.

In September 2021, led by Chairman Yu Chengwang with follow-up investment from Xianju Pharmaceutical, Chengju Pharmaceutical underwent a capital increase and share expansion. By introducing strategic resources such as product varieties, technology, market, and talent from strategic investors, Chengju Pharmaceutical accelerates its transformation and upgrading to become a trusted CMO win-win partner!